Date |
Lecture |
Speaker |
Topic |
2018-09-14 |
1 |
|
Course Introduction |
2018-09-21 |
2 |
王靖媛 |
Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus |
2018-09-28 |
3 |
張凱禮 |
Endogenous transcripts control miRNA levels and activity in mammalian cells by target-directed miRNA degradation |
2018-10-05 |
4 |
賴威仲 |
Discussion |
2018-10-12 |
5 |
|
Review |
2018-10-19 |
6 |
薛阿成 |
Efficient CRISPRCas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells |
2018-10-26 |
7 |
李婉寧 |
Efficient RNA drug delivery using red blood cell extracellular vesicles |
2018-11-02 |
8 |
許佩玲 |
Discussion |
2018-11-09 |
9 |
|
Review |
2018-11-16 |
10 |
蔡亞娟 |
High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis |
2018-11-23 |
11 |
黃允辰 |
RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors |
2018-11-30 |
12 |
湯硯安 |
Discussion |
2018-12-07 |
13 |
|
Review |
2018-12-14 |
14 |
莊媛茹 |
RNA targeting with CRISPR–Cas13 |
2018-12-21 |
15 |
林逸宣 |
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells |
2018-12-28 |
16 |
陳秀梅 |
Discussion |
2019-01-04 |
17 |
|
Review |
2019-01-11 |
18 |
|
Final exam |